NBDC Research ID: hum0067.v1



Aims: To identify novel predictive biomarkers of response to chemotherapy for clear cell carcinoma of the ovary

Methods: whole exome sequencing by using of Illumina HiSeq 2000

Participants/Materials: 110 samples (non-tumor and tumor tissues) from 55 ovarian clear cell carcinoma patients


Data Set IDType of DataCriteriaRelease Date
NGS (Exome) Controlled Access (Type I) 2017/05/18

*Release Note 

* Data users need to apply the Form 2 (Application Form for Using NBDC Human Data) to reach the Controlled Access Data. Learn more





ovarian clear cell carcinoma: 55 cases

(tumor: 55 samples and non-tumor: 55 samples)

Targets Exome
Target Loci for Capture Methods -
Platform Illumina [HiSeq 2000]
Library Source DNAs extracted from tumor and non-tumor tissues
Cell Lines -
Library Construction (kit name) SureSelect Custom Kit (SureSelect Human All Exon V5 + lincRNA)
Fragmentation Methods Ultrasonic fragmentation
Spot Type Paired-end
Read Length (without Barcodes, Adaptors, Primers, and Linkers) 100 bp x 2
Japanese Genotype-phenotype Archive Data set ID JGAD00000000076
Total Data Volume 2 TB (fastq)
Comments (Policies) NBDC policy & P-DIRECT policy



Principal Investigator: Toru Sugiyama

Affiliation: Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine

Project / Group Name: http://p-direct.jfcr.or.jp/english/

Funds / Grants (Research Project Number):

NameTitleProject Number
Project for Development of Innovative Research on Cancer Therapeutics Identifiying the predictive factors for response to chemoherapy in ovarian cancer -



TitleDOIData Set ID
1 -


USRES (Controlled-Access Data)

Principal Investigator: Affiliation: Data in Use (Data Set ID)Period of Data Use
Masaki Mandai Kyoto University Faculty of Medicene, department of Gynecology and Obstetrics JGAD00000000076 2018/10/04-2020/03/31